Results 211 to 220 of about 220,826 (265)

Phase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosus. [PDF]

open access: yesLupus Sci Med
Martins E   +13 more
europepmc   +1 more source

O36 HPV vaccination and cervical screening in SLE patients

open access: yesLupus Science and Medicine
Myles Lewis   +9 more
doaj   +1 more source

Italian Olfactory Identification Test in Systemic Lupus Erythematosus: Association of Olfactory Impairment With Chronic Damage and Anti-β<sub>2</sub>-Glycoprotein I Antibodies. [PDF]

open access: yesACR Open Rheumatol
Di Berardino M   +11 more
europepmc   +1 more source

Discoid lupus

The Journal of Family Practice, 2022
THE COMPARISON A Multicolored (pink, brown, and white) indurated plaques in a butterfly distribution on the face of a 30-year-old woman with a darker skin tone. B Pink, elevated, indurated plaques with hypopigmentation in a butterfly distribution on the face of a 19-year-old woman with a lighter skin tone.
Candrice R, Heath, Richard P, Usatine
openaire   +3 more sources

WHAT IS LUPUS? WHAT IS NOT LUPUS?

Rheumatic Disease Clinics of North America, 1993
Present understanding suggests that lupus reflects a spectrum of syndromes that share many clinical, inflammatory, and immunologic features. Those patients not fulfilling criteria for systemic lupus erythematosus (SLE) do not seem to evolve frequently to classic SLE, tend to have a good prognosis, and may be managed conservatively.
R S, Panush, J M, Greer, K K, Morshedian
openaire   +2 more sources

Systemic lupus erythematosus and lupus nephritis

Nature Reviews Drug Discovery, 2014
The late-stage pipeline for systemic lupus erythematosus (SLE) and lupus nephritis (LN) contains biologics and small-molecule drugs for a broad range of different targets. Koutsokeras and Healy discuss their likely impact on the future SLE and LN market.
Toli, Koutsokeras, Tina, Healy
exaly   +3 more sources

Home - About - Disclaimer - Privacy